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Abstract
Background: Computer-aided dermoscopy using artificial neural networks has been reported to
be an accurate tool for the evaluation of pigmented skin lesions. We set out to determine the
sensitivity and specificity of a computer-aided dermoscopy system for diagnosis of melanoma in
Iranian patients.
Methods: We studied 122 pigmented skin lesions which were referred for diagnostic evaluation
or cosmetic reasons. Each lesion was examined by two clinicians with naked eyes and all of their
clinical diagnostic considerations were recorded. The lesions were analyzed using a microDERM®
dermoscopy unit. The output value of the software for each lesion was a score between 0 and 10.
All of the lesions were excised and examined histologically.
Results: Histopathological examination revealed melanoma in six lesions. Considering only the
most likely clinical diagnosis, sensitivity and specificity of clinical examination for diagnosis of
melanoma were 83% and 96%, respectively. Considering all clinical diagnostic considerations, the
sensitivity and specificity were 100% and 89%. Choosing a cut-off point of 7.88 for dermoscopy
score, the sensitivity and specificity of the score for diagnosis of melanoma were 83% and 96%,
respectively. Setting the cut-off point at 7.34, the sensitivity and specificity were 100% and 90%.
Conclusion: The diagnostic accuracy of the dermoscopy system was at the level of clinical
examination by dermatologists with naked eyes. This system may represent a useful tool for
screening of melanoma, particularly at centers not experienced in the field of pigmented skin
lesions.
Background
The incidence of melanoma is much lower in Asia than in
western countries [1]. Clinicians sometimes misdiagnose
early melanoma especially in areas with lower incidence
of disease [2]. Because advanced cutaneous melanoma is
still incurable, early detection by means of accurate
screening is an important step towards a reduction in
mortality.
Recently, computer-aided dermoscopy using artificial
neural networks (ANNs) has been reported to be an
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accurate tool for the evaluation of pigmented skin lesions
(PSLs) [3-5].
To our knowledge, the accuracy of such system for diagno-
sis of PSL has not been demonstrated in the Middle East,
where most of the patients have Fitzpatrick skin type III-
IV. We set out to determine the sensitivity and specificity
of this system in Iranian patients.
Methods
One hundred and twenty two consecutive PSLs equal or
smaller than 15 mm in diameter, with a clinical diagnosis
of one of the pigmented melanocytic lesions, which were
referred to dermatology clinic of Razi Hospital for diag-
nostic evaluation or cosmetic reasons were included in the
study. Each lesion was examined by two clinicians (an
attending dermatologist and a third year dermatology res-
ident) with naked eyes. They consulted with each other
and recorded all of their clinical diagnostic considerations
in a list. The first diagnostic consideration in the list was
the most likely clinical diagnosis. After clinical examina-
tion, the lesions were analyzed using a microDERM® der-
moscopy unit. The system consists of a special camera,
which had ability to take images at ×15, ×20, ×30, and ×50
magnifications and contains a 752 × 582 pixel charge-
coupled device. The image analysis software was Visiomed
AG (Ver. 3.50) based on an ANN that was trained using
images collected in a Europe-wide multicenter study
(DANAOS) [6]. The output value of the software is a score
ranging from 0 to 10 for each lesion. Informed consent
was obtained from each patient. All of the lesions were
excised and examined histologically. The final diagnosis
was made based on pathological examination.
The study was approved by the Research Ethics Commit-
tee of Razi Hospital.
Results
One hundred and twenty two pigmented skin lesions
from 91 Iranian patients (30 male, 61 female; mean age
32.3 years, age range 6–94) were included in the study.
Melanoma was in the list of clinical diagnostic considera-
tions in 19 lesions. It was the most likely clinical diagnosis
in nine lesions.
Table 1 shows the frequency and dermoscopy score of the
PSLs. Histopathological examination revealed melanoma
in six lesions.
Considering only the most likely clinical diagnosis, sensi-
tivity and specificity of clinical examination for diagnosis
of melanoma were 83% and 96%, respectively. Consider-
ing all clinical diagnostic considerations, the sensitivity
and specificity were 100% and 89%.
Figure 1 shows receiver operating characteristic (ROC)
curve for the separation of benign PSLs and melanoma
Table 1: Frequency and dermoscopy score of the lesions according to histopathological diagnosis.
Histopathological diagnosis No. of lesions Dermoscopy Score
N % Mean Range
Melanoma 6 4.9 8.05 (7.34–8.47)
Lentigo Maligna 3 2.5 7.90 (7.34–8.47)
Lentigo maligna melanoma 2 1.6 8.19 (7.92–8.47)
Acral lentiginous melanoma 1 0.8 8.24 -----
Nonmelanoma 116 95.1 3.86 (0.00–8.35)
Melanocytic 111 91 3.74 (0.00–8.35)
Junctional nevus 4 3.2 2.54 (1.92–3.21)
Compound nevus 10 8.1 2.86 (1.84–5.23)
Intradermal nevus 76 62.3 3.68 (0.00–8.35)
Congenital nevus 7 5.7 5.34 (0.54–7.52)
Blue nevus 5 4.1 2.24 (0.35–3.72)
Combined nevus 2 1.6 4.54 (1.39–7.69)
Dysplastic nevus 7 5.7 5.66 (1.70–8.06)
Nonmelanocytic 5 4.1 6.42 (0.64–8.09)
Seborrheic keratosis 2 1.6 8.00 (7.91–8.09)
Dermatofibroma 1 0.8 7.96 -----
Epidermal nevus 1 0.8 0.64 -----
Actinic keratosis 1 0.8 7.53 -----
Total 122 100 4.06 (0.00–8.47)
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using dermoscopy score in our study. In order to compare
the sensitivity and specificity of clinical examination with
dermoscopy score, we selected two points on the ROC
curve that showed sensitivity and specificity near that of
clinical examination. Choosing a cut-off point of 7.88 for
dermoscopy score, the sensitivity and specificity of the
score for diagnosis of melanoma were 83% and 96%,
respectively. Setting the cut-off point at 7.34, the sensitiv-
ity and specificity were 100% and 90%.
Cohen's kappa statistic was used for evaluation of agree-
ment between diagnostic tests. Kappa values are shown in
Table 2.
Discussion
The ABCD rule is one of the most widely used methods for
evaluating PSLs with the naked eye. However, the diag-
nostic accuracy is not very high [7,8].
Dermoscopy is a noninvasive method that enables clini-
cians to evaluate numerous morphological features that
are not visible to the naked eye. Several studies have
shown that this method improves diagnostic accuracy by
20–30% compared with simple clinical observation [9-
11]. Recently, computer-aided dermoscopy has been
introduced as an additional tool to improve the diagnosis
of pigmented skin lesions. In previous reports, the sensi-
tivity of digital dermoscopy analysis for diagnosis of
melanoma has ranged between 80% and 100% [12,13].
The specificity has ranged between 46% and 98% [14,15].
The diagnostic accuracy of most of the reported softwares
have been at the level of a dermatologist experienced in
dermoscopy and higher than inexperienced clinicians [3-
5,16]. In one study carried out by Seidenari et al, diagnos-
tic accuracy of the software was higher than clinical assess-
ment by an experienced observer [17]. They reported that
the sensitivity and specificity of computer analysis for
diagnosis of melanoma were 93% and 95%, respectively.
In that study, clinical assessments were performed on 20-
fold magnified images. Sensitivity and specificity of
clinical diagnosis made by an experienced observer were
81% and 95%. When an untrained dermatologist assessed
the images, sensitivity and specificity of clinical diagnosis
were 74% and 75%. Another study carried out by Bauer et
al revealed that diagnostic accuracy of computer-aided
dermoscopy was higher than dermoscopy by a trained
dermatologist [15].
Visiomed AG, our image analysis software, has been
trained using images collected from European countries.
However, it could detect melanoma in Iranian patients
with a high level of accuracy. The accuracy of the compu-
terized dermoscopy system in our study is comparable
with that of the most accurate reported systems [5,6,16].
Comparing clinical examination with dermoscopy score
for diagnosis of melanoma in our study, there is no con-
siderable difference in sensitivity and specificity. How-
ever, a larger study with higher power may detect a
possible difference.
Conclusion
This system could not help us to reduce unnecessary exci-
sions or improve early melanoma detection. Nevertheless,
Receiver operating characteristic curve for the separation of  benign pigmented skin lesions and melanoma using dermos- copy score Figure 1
Receiver operating characteristic curve for the separation of 
benign pigmented skin lesions and melanoma using dermos-
copy score.
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Table 2: Cohen's kappa values for evaluation of agreement 
between diagnostic tests.
Tests Kappa value
PD versus CD1 0.65
PD versus CD2 0.44
PD versus DS1 0.50
PD versus DS2 0.46
CD1 versus DS1 0.64
CD2 versus DS2 0.65
CD1, clinical diagnosis when considering only the most likely clinical 
diagnosis; CD2, clinical diagnosis when considering all clinical 
diagnostic considerations; DS1, dermoscopy score when setting the 
cut-off point at 7.88; DS2, dermoscopy score when setting the cut-off 
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it may improve the diagnostic accuracy of an inexperi-
enced clinician in the clinical evaluation of PSLs and rep-
resent a useful tool for screening of melanoma,
particularly at centers not experienced in the field of PSLs.
However, the cost benefit ratio of using this system needs
to be assessed in developing countries with a low inci-
dence of melanoma. Furthermore, it is of paramount
importance to clarify that computer analysis has been
developed in order to assist and not to replace physicians
in the diagnosis of PSLs.
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